C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure

Rationale: Myocardial endothelial cells promote cardiomyocyte hypertrophy, possibly through the release of growth factors. The identity of these factors, however, remains largely unknown, and we hypothesized here that the secreted CTRP9 (C1q-tumor necrosis factor–related protein-9) might act as endothelial-derived protein to modulate heart remodeling in response to pressure overload. Objective: To examine the source of cardiac CTRP9 and its function during pressure overload. Methods and Results: CTRP9 was mainly derived from myocardial capillary endothelial cells. CTRP9 mRNA expression was enhanced in hypertrophic human hearts and in mouse hearts after transverse aortic constriction (TAC). CTRP9 protein was more abundant in the serum of patients with severe aortic stenosis and in murine hearts after TAC. Interestingly, heterozygous and especially homozygous knock-out C1qtnf9 (CTRP9) gene-deleted mice were protected from the development of cardiac hypertrophy, left ventricular dilatation, and dysfunction during TAC. CTRP9 overexpression, in turn, promoted hypertrophic cardiac remodeling and dysfunction after TAC in mice and induced hypertrophy in isolated adult cardiomyocytes. Mechanistically, CTRP9 knock-out mice showed strongly reduced levels of activated prohypertrophic ERK5 (extracellular signal-regulated kinase 5) during TAC compared with wild-type mice, while CTRP9 overexpression entailed increased ERK5 activation in response to pressure overload. Inhibition of ERK5 by a dominant negative MEK5 mutant or by the ERK5/MEK5 inhibitor BIX02189 blunted CTRP9 triggered hypertrophy in isolated adult cardiomyocytes in vitro and attenuated mouse cardiomyocyte hypertrophy and cardiac dysfunction in vivo, respectively. Downstream of ERK5, we identified the prohypertrophic transcription factor GATA4, which was directly activated through ERK5-dependent phosphorylation. Conclusions: The upregulation of CTRP9 during hypertrophic heart disease facilitates maladaptive cardiac remodeling and left ventricular dysfunction and might constitute a therapeutic target in the future.

[1]  Yajing Wang,et al.  C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform. , 2015, American journal of physiology. Endocrinology and metabolism.

[2]  T. Murohara,et al.  C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism , 2015, Molecular and Cellular Biology.

[3]  J. Bauersachs,et al.  Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction , 2015, Circulation.

[4]  A. Nordheim,et al.  Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase. , 2014, Cardiovascular research.

[5]  G. W. Wong,et al.  Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice. , 2014, American journal of physiology. Endocrinology and metabolism.

[6]  M. Seldin,et al.  Metabolic function of the CTRP family of hormones , 2014, Reviews in Endocrine and Metabolic Disorders.

[7]  Yajing Wang,et al.  C1q/Tumor Necrosis Factor–Related Protein-9, a Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling in the Ischemic Mouse Heart via Protein Kinase A Activation , 2013, Circulation.

[8]  M. Seldin,et al.  CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  Joseph A. Hill,et al.  Pathological Ventricular Remodeling: Therapies Part 2 of 2 , 2013, Circulation.

[10]  J. Heineke.  Screening for novel calcium-binding proteins that regulate cardiac hypertrophy: CIB1 as an example. , 2013, Methods in molecular biology.

[11]  K. Walsh,et al.  Cardiovascular and metabolic regulation by the adiponectin/C1q/tumor necrosis factor-related protein family of proteins. , 2012, Circulation.

[12]  T. Murohara,et al.  CTRP9 Protein Protects against Myocardial Injury following Ischemia-Reperfusion through AMP-activated Protein Kinase (AMPK)-dependent Mechanism* , 2012, The Journal of Biological Chemistry.

[13]  J. Heineke.  Wag the dog: how endothelial cells regulate cardiomyocyte growth. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Yajing Wang,et al.  Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNFα-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice , 2012, Basic Research in Cardiology.

[15]  William E Louch,et al.  Methods in cardiomyocyte isolation, culture, and gene transfer. , 2011, Journal of molecular and cellular cardiology.

[16]  W. Pu,et al.  Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo , 2011, Proceedings of the National Academy of Sciences.

[17]  H. Katus,et al.  Comparison of IL-10 and MCP-1-7ND gene transfer with AAV9 vectors for protection from murine autoimmune myocarditis. , 2011, Cardiovascular research.

[18]  R. Geffers,et al.  GATA6 Promotes Angiogenic Function and Survival in Endothelial Cells by Suppression of Autocrine Transforming Growth Factor β/Activin Receptor-like Kinase 5 Signaling* , 2010, The Journal of Biological Chemistry.

[19]  M. Simons,et al.  Cell Communications in the Heart , 2010, Circulation.

[20]  H. Drexler,et al.  CIB1 is a Regulator of Pathological Cardiac Hypertrophy , 2010, Nature Medicine.

[21]  E. Cartwright,et al.  Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload–Induced Apoptosis in the Heart , 2010, Circulation research.

[22]  H. Lodish,et al.  Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  D. Michele,et al.  Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression. , 2008, American journal of physiology. Heart and circulatory physiology.

[24]  E. Olson,et al.  Cardiac plasticity. , 2008, The New England journal of medicine.

[25]  P. Carmeliet,et al.  Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. , 2007, The Journal of clinical investigation.

[26]  B. Aronow,et al.  Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. , 2007, The Journal of clinical investigation.

[27]  G. D. De Keulenaer,et al.  Role of Neuregulin-1/ErbB Signaling in Cardiovascular Physiology and Disease: Implications for Therapy of Heart Failure , 2007, Circulation.

[28]  I. Komuro,et al.  p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload , 2007, Nature.

[29]  R. Shohet,et al.  Endogenous Endothelin-1 Is Required for Cardiomyocyte Survival In Vivo , 2006, Circulation.

[30]  J. Molkentin,et al.  Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.

[31]  I. Shiojima,et al.  Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload , 2006, Hypertension.

[32]  F. Luscinskas,et al.  Isolation and culture of murine heart and lung endothelial cells for in vitro model systems. , 2006, Methods in molecular biology.

[33]  W. Funk,et al.  PAQR Proteins: A Novel Membrane Receptor Family Defined by an Ancient7-Transmembrane Pass Motif , 2005, Journal of Molecular Evolution.

[34]  W. Koch,et al.  Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress , 2002, Circulation.

[35]  J. Molkentin,et al.  The Transcription Factor GATA4 Is Activated by Extracellular Signal-Regulated Kinase 1- and 2-Mediated Phosphorylation of Serine 105 in Cardiomyocytes , 2001, Molecular and Cellular Biology.

[36]  F. Charron,et al.  Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. , 2001, Genes & development.

[37]  E. Olson,et al.  Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy , 2001, The EMBO journal.

[38]  R. Hajjar,et al.  Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure , 2001, Circulation.